Total Positions
19
Quarter
2022 Q4
Top Holding
PCVX (31.5%)
Top 10 Concentration
96.9%
Turnover Rate
23.4%
Sector HHI
0.18
Items per page:
1-19 of 19
| Stock | History | Sector / Type | Port % | Prev % | Rank / Prev | Conviction | Change | % Change | Influence | Shares | Mkt Value | Avg Cost | Price Held | 1st Owned | Source | Source Date | Date Reported |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
PCVX
VAXCYTE INC
|
|
Healthcare | 31.54% | 34.21% |
#1
Prev: #1
|
10.0 | -2,149,661 | -51.6% |
P
S
|
2,019,057 | $96,813,783,000 | 2020 Q2 | 13F Filing | 2022-12-31 | 2023-02-14 (Est.) | ||
|
VRNA
VERONA PHARMA P...
|
|
Unknown | 20.92% | 8.58% |
#2
3
Prev: #5
|
8.4 | no change | no change |
P
S
|
2,457,500 | $64,214,475,000 | 2018 Q3 | 13F Filing | 2022-12-31 | 2023-02-14 (Est.) | ||
|
VERA
VERA THERAPEUTI...
|
|
Healthcare | 18.66% | 21.57% |
#3
1
Prev: #2
|
7.5 | no change | no change |
P
S
|
2,960,231 | $57,280,470,000 | 2021 Q2 | 13F Filing | 2022-12-31 | 2023-02-14 (Est.) | ||
|
HLVX
HILLEVAX INC
|
|
Unknown | 10.02% | 10.74% |
#4
1
Prev: #3
|
4.0 | no change | no change |
P
S
|
1,838,486 | $30,757,871,000 | 2022 Q2 | 13F Filing | 2022-12-31 | 2023-02-14 (Est.) | ||
|
ACET
ADICET BIO INC
|
|
Healthcare | 6.16% | 10.26% |
#5
1
Prev: #4
|
2.5 | no change | no change |
P
S
|
2,115,385 | $18,911,542,000 | 2021 Q1 | 13F Filing | 2022-12-31 | 2023-02-14 (Est.) | ||
|
PHAT
PHATHOM PHARMAC...
|
|
Healthcare | 5.25% | 5.44% |
#6
Prev: #6
|
2.1 | no change | no change |
P
S
|
1,435,106 | $16,101,889,000 | 2019 Q4 | 13F Filing | 2022-12-31 | 2023-02-14 (Est.) | ||
|
N/A
RENEO PHARMACEU...
|
—
|
Unknown | 1.57% | 2.38% |
#7
Prev: #7
|
0.6 | no change | no change |
P
S
|
2,073,957 | $4,832,320,000 | — | 13F Filing | 2022-12-31 | 2023-02-14 (Est.) | ||
|
SIEN
SIENTRA INC
|
|
Unknown | 1.11% | 0.37% |
#8
6
Prev: #14
|
0.4 | no change | no change |
P
S
|
1,673,589 | $3,397,386,000 | 2014 Q4 | 13F Filing | 2022-12-31 | 2023-02-14 (Est.) | ||
|
N/A
JASPER THERAPEU...
|
—
|
Unknown | 0.89% | 1.52% |
#9
1
Prev: #8
|
0.4 | no change | no change |
P
S
|
5,628,558 | $2,718,594,000 | — | 13F Filing | 2022-12-31 | 2023-02-14 (Est.) | ||
|
SLNO
SOLENO THERAPEU...
|
|
Healthcare | 0.78% | 0.69% |
#10
3
Prev: #13
|
0.3 | no change | no change |
P
S
|
1,201,506 | $2,378,982,000 | 2018 Q4 | 13F Filing | 2022-12-31 | 2023-02-14 (Est.) | ||
|
N/A
NUCANA PLC
|
—
|
Unknown | 0.72% | 1.16% |
#11
2
Prev: #9
|
0.3 | no change | no change |
P
S
|
3,333,333 | $2,200,000,000 | — | 13F Filing | 2022-12-31 | 2023-02-14 (Est.) | ||
|
N/A
EFFECTOR THERAP...
|
—
|
Unknown | 0.67% | 0.93% |
#12
2
Prev: #10
|
0.3 | no change | no change |
P
S
|
4,822,114 | $2,063,865,000 | — | 13F Filing | 2022-12-31 | 2023-02-14 (Est.) | ||
|
SPRB
SPRUCE BIOSCIEN...
|
|
Healthcare | 0.64% | 0.85% |
#13
1
Prev: #12
|
0.3 | no change | no change |
P
S
|
1,792,518 | $1,966,392,000 | 2022 Q3 | 13F Filing | 2022-12-31 | 2023-02-14 (Est.) | ||
|
PRTK
PARATEK PHARMAC...
|
|
Unknown | 0.63% | 0.91% |
#14
3
Prev: #11
|
0.3 | no change | no change |
P
S
|
1,041,131 | $1,946,915,000 | 2014 Q4 | 13F Filing | 2022-12-31 | 2023-02-14 (Est.) | ||
|
CBAY
CYMABAY THERAPE...
|
|
Unknown | 0.27% | 0.16% |
#15
Prev: #15
|
0.1 | no change | no change |
P
S
|
131,036 | $821,596,000 | 2015 Q3 | 13F Filing | 2022-12-31 | 2023-02-14 (Est.) | ||
|
XCUR
EXICURE INC
|
|
Healthcare | 0.11% | 0.15% |
#16
Prev: #16
|
0.0 | no change | no change |
P
S
|
281,636 | $323,881,000 | 2019 Q3 | 13F Filing | 2022-12-31 | 2023-02-14 (Est.) | ||
|
AGLE
AEGLEA BIOTHERA...
|
|
Unknown | 0.04% | 0.04% |
#17
1
Prev: #18
|
0.0 | no change | no change |
P
S
|
240,500 | $108,225,000 | 2019 Q1 | 13F Filing | 2022-12-31 | 2023-02-14 (Est.) | ||
|
N/A
MOLECULAR TEMPL...
|
—
|
Unknown | 0.02% | 0.05% |
#18
1
Prev: #17
|
0.0 | no change | no change |
P
S
|
200,000 | $66,000,000 | — | 13F Filing | 2022-12-31 | 2023-02-14 (Est.) | ||
|
N/A
OBSEVA SA
|
—
|
Unknown | 0.00% | 0.00% |
#19
Prev: #19
|
0.0 | no change | no change |
P
S
|
87,999 | $12,760,000 | — | 13F Filing | 2022-12-31 | 2023-02-14 (Est.) |
Showing 1-19 of 19 holdings